Brief: Sk Bioscience Co Ltd Wins 39 Billion Won Order From Novavax Inc
18/07/2022 23:51
July 19 (Reuters) - SK Bioscience Co Ltd 302440.KS :
* SK BIOSCIENCE CO LTD: WINS 39 BILLION WON ($29.59
million)ORDER
FROM NOVAVAX INC
Further company coverage: 302440.KS
($1 = 1,318.1900 won)
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine